SKU 072117Ethiqa XR buprenorphine ExtendedRele

State & local contract award Virginia Awarded

Contract number
A236_P0355017
Awardee
COVETRUS NORTH AMERICA
Contracting organization
Virginia Commonwealth University
Cumulative value
$410.15

About this award

Covetrus North America has been awarded a contract by Virginia Commonwealth University (VCU) effective September 9, 2026, for the supply of pharmaceutical products. The contract encompasses the delivery of Ethiqa XR buprenorphine Extended Release medication to VCU Procurement. The award is valued at approximately $410, with a unit price of $410.15 for a single unit delivery.

The contract specifies procurement of one unit of Ethiqa XR buprenorphine Extended Release, a controlled pharmaceutical product designated under SKU 072117. As the prime contractor, Covetrus North America is responsible for fulfilling the delivery requirements to VCU Procurement in Virginia. The contract represents a direct goods purchase with a cumulative value of $410, reflecting a single-line-item transactional award rather than a multi-year service engagement.

Line items

Item Total
SKU 072117Ethiqa XR buprenorphine ExtendedRele 1 Each × $410.15 $410.15

Award details come from logi.cgieva.com. Updated .

Quick answers

Who was awarded contract A236_P0355017?

Contract A236_P0355017 was awarded to COVETRUS NORTH AMERICA by Virginia Commonwealth University on September 9, 2026.

How much is contract A236_P0355017 worth?

Its cumulative value is $410.15.

On GovTribe

See this award's full record

  • Every line item and file
  • The contract it was ordered under and its other orders
  • Similar state and local awards and opportunities
  • Ask GovTribe AI about this award